Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the Evidence. Alzforum, 16 Apr 2021 Müller T. Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the Evidence.